Rockefeller Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $16.2M | Buy |
430,557
+9,540
| +2% | +$358K | 0.26% | 89 |
|
|
2017
Q3 | $15.3M | Sell |
421,017
-251,433
| -37% | -$9.16M | 0.29% | 79 |
|
|
2017
Q2 | $26.5M | Buy |
672,450
+28,104
| +4% | +$1.11M | 0.53% | 49 |
|
|
2017
Q1 | $20.2M | Sell |
644,346
-4,431
| -0.7% | -$139K | 0.4% | 57 |
|
|
2016
Q4 | $20.3M | Buy |
648,777
+4,701
| +0.7% | +$147K | 0.41% | 53 |
|
|
2016
Q3 | $25.9M | Hold |
644,076
| – | – | 0.54% | 49 |
|
|
2016
Q2 | $21.4M | Sell |
644,076
-7,260
| -1% | -$241K | 0.43% | 49 |
|
|
2016
Q1 | $19.2M | Sell |
651,336
-30,156
| -4% | -$887K | 0.37% | 54 |
|
|
2015
Q4 | $17.9M | Sell |
681,492
-74,940
| -10% | -$1.97M | 0.35% | 62 |
|
|
2015
Q3 | $17.9M | Sell |
756,432
-72,288
| -9% | -$1.71M | 0.36% | 65 |
|
|
2015
Q2 | $19.7M | Sell |
828,720
-2,664
| -0.3% | -$63.2K | 0.41% | 58 |
|
|
2015
Q1 | $19.7M | Buy |
831,384
+10,764
| +1% | +$256K | 0.43% | 53 |
|
|
2014
Q4 | $17.4M | Buy |
820,620
+17,262
| +2% | +$366K | 0.38% | 61 |
|
|
2014
Q3 | $13.7M | Sell |
803,358
-8,202
| -1% | -$140K | 0.3% | 67 |
|
|
2014
Q2 | $11.6M | Sell |
811,560
-29,688
| -4% | -$425K | 0.26% | 83 |
|
|
2014
Q1 | $10.4M | Buy |
841,248
+15,018
| +2% | +$186K | 0.23% | 99 |
|
|
2013
Q4 | $9.06M | Sell |
826,230
-178,830
| -18% | -$1.96M | 0.2% | 110 |
|
|
2013
Q3 | $11.7M | Sell |
1,005,060
-422,730
| -30% | -$4.91M | 0.27% | 89 |
|
|
2013
Q2 | $16M | Buy |
+1,427,790
| New | +$16M | 0.38% | 67 |
|